Viewing Study NCT00645892


Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2026-03-17 @ 10:42 PM
Study NCT ID: NCT00645892
Status: COMPLETED
Last Update Posted: 2008-03-28
First Post: 2008-03-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Sponsor: Abbott
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module